iCrowd Newswire – Aug 11, 2020
Sleep disorder is also known as sominpathy or insomnia is a medical disorder in which the patient experience difficulty in sleep maintenance or sleep initiation. Symptoms for this disorder include mental, physical, social, and emotional functions. Lack of sleep has a negative impact on the health of a person. The prevalence of sleep disorders has been significantly increased which is a primary factor fostering the market growth. Reportedly, in the United States, over 75% of people aged between 20 and 59 years have sleeping difficulties frequently. According to AMA, the Global Sleep Disorder Treatment Drugs market is expected to see growth rate of 5.5%.
Advance Market Analytics released a new market study on Global Sleep Disorder Treatment Drugs Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Sleep Disorder Treatment Drugs Forecast till 2027*.
Key Players in This Report Include,
Pfizer (United States), Sanofi (France), Merck Sharp & Dohme Corporation (United States), GlaxoSmithKline (United Kingdom), Koninklijke Philips N.V. (Netherlands), Takeda Pharmaceutical Company (Japan), Leva Pharmaceutical Industries (Pakistan), Cardinal Health, Inc. (United States), Becton Dickson and Company (United States) and Natus Medical orporated (United States)
Click to get Global Sleep Disorder Treatment Drugs Market Research Sample PDF Copy Here @: https://www.advancemarketanalytics.com/sample-report/57404-global-sleep-disorder-treatment-drugs-market
Relevant features of the study that are being offered with major highlights from the report :
1) How Impact of COVID-19 / Economic Slowdown in 2020 is considered in the Estimates of Study?
Analyst at AMA have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact Analysis of COVID-19 on Global Sleep Disorder Treatment Drugs Market along with tables and graphs related to various country and segments showcasing impact on growth trends.
2) Can Market be broken down by different set of application and types?
Additional segmentation / Market breakdown is possible subject to data availability, feasibility and depending upon timeline and toughness of survey. However a detailed requirement needs to be prepared before making any final confirmation.
** An additional country of your interest can be included at no added cost feasibility test would be conducted by Analyst team of AMA based on the requirement shared and accordingly deliverable time will also be disclosed.
Enquire for customization in Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/57404-global-sleep-disorder-treatment-drugs-market
Latest news and Recent Development in Sleep Disorder Treatment Drugs Market:
March 2019, Jazz Pharmaceuticals plc announced that the Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). and January 2019, New Drug Application for Insomnia Disorder Treatment i.e.Lemborexant Submitted to FDA. Lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder. This application was based on the results of two pivotal Phase 3 clinical studies in patients with insomnia.
In March 2018, Drive DeVilbiss Healthcare introduced the next generation Trotter Mobility Chair. The product offers parents and caregivers a lightweight, foldable alternative to heavier wheelchair-style mobility bases. The new generation Trotter features a padded seat and back upholstery at the same low price as the original version. New accessories include angle adjustable footplates, anti-tippers, contoured headwings, headrest extension, canopy, under-seat carrier and Poziform ankle positioners.
November 2018, the European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and an application submitted by Sanofi.
|Market size available for years||2018–2027|
|Base year considered||2019|
|Forecast units||Value (USD Million)|
|Market Segmentation||by Type (Prescription-based Drugs, OTC Drugs, Herbal Drugs), Application (Hospitals, Clinics, Research Centers, Others), Sleep disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking), Devices (Positive Airway Pressure (PAP) Devices, Facial Interfaces, Oral Appliances, Adaptive Servo-Ventilators (ASVs), Others)|
|Geographies covered||North America, Europe, Asia Pacific, Middle East & Africa, and South America|
- Increasing Incidence of Depression & Medical Disorder
- Rising Geriatric Population and Associated Sleep Disorder
- High Usage of Sleep Apnea Devices and Growing Healthcare Facilities
- Introduction of Home Sleep Test Kits and Wearable Monitors
- Advent of Continuous Positive Airway Pressure (CPAP) Therapy
- Affordable Reimbursement Scenario for Drugs prescribed in Insomnia Treatment
- Side Effects Associated with the Drug used to Treat Sleep Disorder
- Rising Investment on Research and Development of Drugs for the Sleep disorder
- Patent Expiration of Sleep Disorder Treatment Drugs
To comprehend Global Sleep Disorder Treatment Drugs market dynamics in the world mainly, the worldwide Sleep Disorder Treatment Drugs market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas.
• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, Colombia and Brazil.
• Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa.
• Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia.
Buy Full Copy Global Sleep Disorder Treatment Drugs Report 2019 @ https://www.advancemarketanalytics.com/buy-now?format=1&report=57404
Try a limited scope research document specific to Country or Regional matching your objective.
GET FULL COPY OF United States Sleep Disorder Treatment Drugs market study @ ——— USD 2000
And, Europe Sleep Disorder Treatment Drugs market study @ ——— USD 2500
Some Strategic Points Covered in Table of Content of Global Sleep Disorder Treatment Drugs Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Sleep Disorder Treatment Drugs market
Chapter 2: Exclusive Summary – the basic information of the Sleep Disorder Treatment Drugs Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Sleep Disorder Treatment Drugs
Chapter 4: Presenting the Sleep Disorder Treatment Drugs Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5-7: Displaying the by Type, End User and Region 2014-2019. Evaluating the leading manufacturers of the Sleep Disorder Treatment Drugs market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile. Market Estimates by segments, by countries and by manufacturers with revenue share and sales by key countries in these various countries (2020-2025).
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Sleep Disorder Treatment Drugs Market is a valuable source of guidance for individuals and companies.
Browse for Full Report at @: https://www.advancemarketanalytics.com/reports/57404-global-sleep-disorder-treatment-drugs-market
Key highlights of the Study:
- CAGR of the market during the forecast period 2019-2025
- Detailed information on factors that will accelerate the growth.
- Insights on upcoming trends and changes in consumer behavior
- Uncovering market’s competitive landscape
- Comprehensive information about factors that will challenge the growth
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
Keywords: Sleep Disorder Treatment Drugs Austria Market, Sleep Disorder Treatment Drugs Europe Market, Sleep Disorder Treatment Drugs France Market, Sleep Disorder Treatment Drugs Germany Market, Sleep Disorder Treatment Drugs Market Analysis, Sleep Disorder Treatment Drugs Market Outlook, Sleep Disorder Treatment Drugs Spain Market, Sleep Disorder Treatment Drugs Uk Market